Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Cancer will fix everything

<< Previous

Bullboard Posts

Next >>

Comment by Momo25on Sep 18, 2024 3:33pm

68 Views

Post# 36229656

RE:RE:Cancer will fix everything

Your comment is completely irrelevant. Maybe you bought TH at $1.5 and you expect to make few bucks, good for you. However, be aware that most of the people who complain in this forum have bought their SP higher than 5 bucks before the reverse split, meaning it is worth $20+ after the reverse split. No one with minimum QI rate will sell his shares at the current price. We prefer TH bamckrupted than taking a stupid hit like you suggest. Morality, if there is someone to shut up is YOU!

<< Previous

Bullboard Posts

Next >>

FLYHT and WestJet partner on weather forecasting